These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38211032)

  • 1. On Diseases of the Liver.
    West J Med Surg; 1853; 12(5-6):445-450. PubMed ID: 38211032
    [No Abstract]   [Full Text] [Related]  

  • 2. "Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)".
    Plessier A; Bureau C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):407-409. PubMed ID: 32360056
    [No Abstract]   [Full Text] [Related]  

  • 3. LESIONS OF THE LIVER IN HEREDITARY METABOLIC DISEASES.
    LANDING BH
    Ann N Y Acad Sci; 1963 Dec; 111():399-411. PubMed ID: 14090352
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research advances in nutritional assessment methods in children with chronic liver diseases].
    Tong S; Zhu Y; Wan CM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):596-600. PubMed ID: 28506356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell therapies for liver diseases.
    Yu Y; Fisher JE; Lillegard JB; Rodysill B; Amiot B; Nyberg SL
    Liver Transpl; 2012 Jan; 18(1):9-21. PubMed ID: 22140063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Soret J; Debray D; Fontbrune FS; Kiladjian JJ; Saadoun D; Latour RP; Valla D; Hernandez-Gea V; Hillaire S; Dutheil D; Plessier A; Bureau C; De Raucourt E
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):410-419. PubMed ID: 32651075
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotherapy for autoimmune liver diseases.
    Liu M; Chen Y; Zheng S; Duan Z; Zhang JY
    Curr Pharm Biotechnol; 2014; 15(6):510-5. PubMed ID: 25213359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application.
    Wang Y; Shi C; Guo J; Zhang Y; Gong Z
    J Clin Transl Hepatol; 2023 Nov; 11(6):1413-1424. PubMed ID: 37719956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Payancé A; Ceccaldi PF; De Raucourt E; Valla D; Hillaire S; Dutheil D; Hernandez-Gea V; Bureau C; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):433-437. PubMed ID: 32278776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver involvement in endocrine diseases].
    Wang QY; Ou XJ; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2022 Apr; 30(4):352-356. PubMed ID: 35545559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver Transplantation as Treatment for Rare Diseases in Adults].
    Bauschke A; Malessa C; Rauchfuss F; Zanow J; Settmacher U
    Zentralbl Chir; 2017 Apr; 142(2):169-179. PubMed ID: 24241952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional and histochemical changes in the pancreas in diseases and after surgery of the liver, gallbladder, stomach and pancreas. (Review of Russian and foreign literature)].
    VOLKOVA LP
    Vestn Khir Im I I Grek; 1962 Feb; 88():129-39. PubMed ID: 13926620
    [No Abstract]   [Full Text] [Related]  

  • 13. Autophagy in hepatic macrophages can be regulator and potential therapeutic target of liver diseases: A review.
    Ge J; Li H; Yang JQ; Yue Y; Lu SY; Nie HY; Zhang T; Sun PM; Yan HF; Sun HW; Yang JW; Zhou JL; Cui Y
    Medicine (Baltimore); 2023 May; 102(19):e33698. PubMed ID: 37171337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases.
    Wu YC; Yao Y; Tao LS; Wang SX; Hu Y; Li LY; Hu S; Meng X; Yang DS; Li H; Xu T
    Cell Signal; 2023 Feb; 102():110550. PubMed ID: 36464104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive hepatology: An ounce of prevention or pounds of cure to curb liver diseases.
    Bhadoria AS; Mohapatra A; Gupta R; Chawla YK; Kant R; Nundy S
    J Family Med Prim Care; 2023 Mar; 12(3):419-421. PubMed ID: 37122647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver in systemic disease.
    Shimizu Y
    World J Gastroenterol; 2008 Jul; 14(26):4111-9. PubMed ID: 18636653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine in liver diseases: Pharmacology and toxicology.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Front Pharmacol; 2022; 13():1030173. PubMed ID: 36324678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.
    Mokhtari F; Mohebbi SR; Sharifian A; Ramandi M; Razzaghi MR
    Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S10-S23. PubMed ID: 35154598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomics Research Progress on Liver Diseases.
    Yu M; Zhu Y; Cong Q; Wu C
    Can J Gastroenterol Hepatol; 2017; 2017():8467192. PubMed ID: 28321390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoids and liver diseases].
    Liu XW; Liu PY; Jiang C; Gao YH
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):557-560. PubMed ID: 30317784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.